TABLE OF CONTENTS
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL BIONIC EAR MARKET, BY DEVICE TYPE
6.1. Overview
6.2. Cochlear implant
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.3. Auditory Brainstem Implants
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.4Bone-anchored hearing aid
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7. GLOBAL BIONIC EAR MARKET, BY END USER
7.1. Overview
7.2. Research Institutes
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.3. Hearing Clinics
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.4. Hospitals
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
8. GLOBAL BIONIC EAR MARKET BY REGION
8.1. Overview
8.2. North America
8.2.1. US
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. Spain
8.3.5. UK
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. COMPANY LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Bionic Ear Market
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Bionic Ear Market
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger &Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2020
9.8.2. Major Players R&D Expenditure, 2020
10. COMPANY PROFILES
10.1. Advanced Bionics
10.1.1. Company Overview
10.1.2. Products Offered
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Sonova
10.2.1. Company Overview
10.2.2. Products Offered
10.2.3. Financial Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Cochlear
10.3.1. Company Overview
10.3.2. Products Offered
10.3.3. Financial Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. MED-EL
10.4.1. Company Overview
10.4.2. Products Offered
10.4.3. Financial Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. WS Audiology
10.5.1. Company Overview
10.5.2. Products Offered
10.5.3. Financial Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Oticon
10.6.1. Company Overview
10.6.2. Products Offered
10.6.3. Financial Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Hangzhou Nurotron
10.7.1. Company Overview
10.7.2. Products Offered
10.7.3. Financial Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Listent Medical
10.8.1. Company Overview
10.8.2. Products Offered
10.8.3. Financial Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Medtronic PLC
10.9.1. Company Overview
10.9.2. Products Offered
10.9.3. Financial Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Edward Lifesciences corporation
10.10.1. Company Overview
10.10.2. Products Offered
10.10.3. Financial Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Ekso Bionics
10.11.1. Company Overview
10.11.2. Products Offered
10.11.3. Financial Overview
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Ossur
10.12.1. Company Overview
10.12.2. Products Offered
10.12.3. Financial Overview
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. LifeNet Health
10.13.1. Company Overview
10.13.2. Products Offered
10.13.3. Financial Overview
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
10.14. William Demant Holdings
10.14.1. Company Overview
10.14.2. Products Offered
10.14.3. Financial Overview
10.14.4. Key Developments
10.14.5. SWOT Analysis
10.14.6. Key Strategies
10.15. Terumo Corporation
10.15.1. Company Overview
10.15.2. Products Offered
10.15.3. Financial Overview
10.15.4. Key Developments
10.15.5. SWOT Analysis
10.15.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BIONIC EAR MARKET SYNOPSIS, 2022–2030
TABLE 2 GLOBAL BIONIC EAR MARKET ESTIMATES &FORECAST, 2022–2030(USD MILLION)
TABLE 3 GLOBAL BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 4 GLOBAL BIONIC EAR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 5 NORTH AMERICA: BIONIC EAR MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 6 NORTH AMERICA: BIONIC EAR MARKET, BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 7 NORTH AMERICA: BIONIC EAR MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 8 US: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 9 US: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 10 CANADA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 11 CANADA: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 12 EUROPE: BIONIC EAR MARKET BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 13 EUROPE: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 14 EUROPE: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 15 GERMANY: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 16 GERMANY: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 17 FRANCE: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 18 FRANCE: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 19 ITALY: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 20 ITALY: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 21 SPAIN: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 22 SPAIN: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 23 UK: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 24 UK: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 25 REST OF EUROPE: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 26 REST OF EUROPE: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 27 ASIA-PACIFIC: BIONIC EAR MARKET BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 30 JAPAN: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 31 JAPAN: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 32 CHINA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 33 CHINA: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 34 INDIA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 35 INDIA: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 36 AUSTRALIA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 37 AUSTRALIA: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 38 SOUTH KOREA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 39 SOUTH KOREA: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 40 REST OF ASIA-PACIFIC: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 41 REST OF ASIA-PACIFIC: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 42 REST OF THE WORLD: BIONIC EAR MARKET BY REGION, 2022–2030 (USD MILLION)
TABLE 43 REST OF THE WORLD: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 44 REST OF THE WORLD: BIONIC EAR MARKET BY END USER, 2022–2030 (USD MILLION)
TABLE 45 MIDDLE EAST: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 46 MIDDLE EAST: BIONIC EAR MARKET END USER, 2022–2030 (USD MILLION)
TABLE 47 AFRICA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 48 AFRICA: BIONIC EAR MARKET END USER, 2022–2030 (USD MILLION)
TABLE 49 LATIN AMERICA: BIONIC EAR MARKET BY DEVICE TYPE, 2022–2030 (USD MILLION)
TABLE 50 LATIN AMERICA: BIONIC EAR MARKET END USER, 2022–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIONIC EAR MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIONIC EAR MARKET
FIGURE 4 GLOBAL BIONIC EAR MARKET SHARE, BY DEVICE TYPE, 2020 (%)
FIGURE 5 GLOBAL BIONIC EAR MARKET SHARE, BY END USER, 2020 (%)
FIGURE 6 GLOBAL BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 NORTH AMERICAS: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 EUROPE: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 ASIA-PACIFIC: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 REST OF THE WORLD: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 GLOBAL BIONIC EAR MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 12 ADVANCED BIONICS KEY FINANCIALS
FIGURE 13 ADVANCED BIONICS SWOT ANALYSIS
FIGURE 14 SONOVAKEY FINANCIALS
FIGURE 15 SONOVASWOT ANALYSIS
FIGURE 16 COCHLEARKEY FINANCIALS
FIGURE 17 COCHLEAR SWOT ANALYSIS
FIGURE 18 MED-EL KEY FINANCIALS
FIGURE 19 MED-ELSWOT ANALYSIS
FIGURE 20 WS AUDIOLOGY KEY FINANCIALS
FIGURE 21 WS AUDIOLOGY SWOT ANALYSIS
FIGURE 22 OTICON KEY FINANCIALS
FIGURE 23 OTICON SWOT ANALYSIS
FIGURE 24 HANGZHOU NUROTRON KEY FINANCIALS
FIGURE 25 HANGZHOU NUROTRON SWOT ANALYSIS
FIGURE 26 LISTENT MEDICAL KEY FINANCIALS
FIGURE 27 LISTENT MEDICAL SWOT ANALYSIS
FIGURE 28 MEDTRONIC PLC KEY FINANCIALS
FIGURE 29 MEDTRONIC PLC SWOT ANALYSIS
FIGURE 30 EDWARD LIFESCIENCES CORPORATION KEY FINANCIALS
FIGURE 31 EDWARD LIFESCIENCES CORPORATION SWOT ANALYSIS
FIGURE 32 EKSO BIONICS KEY FINANCIALS
FIGURE 33 EKSO BIONICS SWOT ANALYSIS
FIGURE 34 OSSUR KEY FINANCIALS
FIGURE 35 OSSUR SWOT ANALYSIS
FIGURE 36 LIFENET HEALTH KEY FINANCIALS
FIGURE 37 LIFENET HEALTH SWOT ANALYSIS
FIGURE 38 WILLIAM DEMANT HOLDINGS KEY FINANCIALS
FIGURE 39 WILLIAM DEMANT HOLDINGS SWOT ANALYSIS
FIGURE 40 TERUMO CORPORATION KEY FINANCIALS
FIGURE 41 TERUMO CORPORATION SWOT ANALYSIS